Palvella Therapeutics Inc. (PVLA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Palvella Therapeutics Inc...

    NASDAQ: PVLA · Real-Time Price · USD
    67.53
    1.75 (2.66%)
    At close: Oct 06, 2025, 10:18 AM

    Palvella Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
    Cash & Equivalents
    		 70.43M 75.63M 19.36M 19.73M 6.25M 17.4M 32.89M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a 8.97M 11.92M
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a n/a n/a 287K
    Receivables
    		 1.98M 1.98M 879K 4.67M n/a 6.04M 1.04M
    Inventory
    		 n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 1.34M 1.83M 280K 649K 144K 6.28M 13.23M
    Total Current Assets
    		 73.75M 79.44M 20.52M 25.05M 6.39M 38.68M 59.09M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a n/a n/a n/a n/a n/a 287K
    Total Assets
    		 73.75M 79.44M 20.52M 25.05M 6.39M 38.68M 59.38M
    Account Payables
    		 4.56M 4.44M 801K 969K 1.02M 3.37M 2.82M
    Deferred Revenue
    		 n/a n/a n/a n/a n/a n/a 994K
    Short-Term Debt
    		 n/a n/a n/a n/a n/a n/a 12.29M
    Other Current Liabilities
    		 3.69M 3.3M 1.15M 2.27M 602K 2.1M 4.03M
    Total Current Liabilities
    		 9.62M 8.98M 4.25M 6.35M 2.73M 11.92M 28.87M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 16.35M 14.88M n/a n/a 9.93M n/a n/a
    Total Long-Term Liabilities
    		 16.35M 14.88M n/a n/a 9.93M n/a n/a
    Total Liabilities
    		 25.97M 23.86M 4.25M 6.35M 12.66M 11.92M 28.87M
    Total Debt
    		 n/a n/a n/a n/a n/a n/a 12.29M
    Book Value
    		 47.78M 55.58M 16.27M 18.7M -6.27M 26.76M 30.51M
    Book Value Per Share
    		 4.32 24.97 12.32 14.40 -4.94 21.63 24.68
    Common Stock
    		 11K 11K 1K 1K n/a 98K 99K
    Retained Earnings
    		 -111.39M -101.92M -326.33M -323.45M -78.84M -314.96M -310.38M
    Comprehensive Income
    		 -111K -3K -316K -436K n/a 28K -339K
    Shareholders Equity
    		 47.78M 55.58M 16.27M 18.7M -6.27M 26.76M 30.51M
    Total Investments
    		 n/a n/a n/a n/a n/a 8.97M 11.92M

    Add to Watchlist